SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Galectin Therapeutics Inc. to Contact Brower Piven Before the September 29, 2014 Lead Plaintiff Deadline in Class